Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment
about
Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicineSpherical and tubule nanocarriers for sustained drug releaseNanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatmentControlled Drug Release from Pharmaceutical NanocarriersCombination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cellsCurrent Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Highly scalable, closed-loop synthesis of drug-loaded, layer-by-layer nanoparticlesLayer-by-layer assembled fluorescent probes in the second near-infrared window for systemic delivery and detection of ovarian cancerSpatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.siRNA Delivery Strategies: A Comprehensive Review of Recent Developments.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.High drug-loading nanomedicines: progress, current status, and prospects.A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecinMolecular extraction in single live cells by sneaking in and out magnetic nanomaterials.P-glycoprotein-dependent trafficking of nanoparticle-drug conjugatesBimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.Multi-layered nanoparticles for combination gene and drug delivery to tumors.Layer-by-layer assembled antisense DNA microsponge particles for efficient delivery of cancer therapeutics.Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries.Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging.Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug ReleaseDrug co-loading and pH-sensitive release core-shell nanoparticles via layer-by-layer assembly.Spatio-Temporal Control of LbL Films for Biomedical Applications: From 2D to 3DpH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle.Control of polymeric nanoparticle size to improve therapeutic delivery.Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence.ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast CancerA Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAsCurrent development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.Nanocoating for biomolecule delivery using layer-by-layer self-assembly.Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.Cancer nanomedicine: from drug delivery to imaging.Enhancing endosomal escape for nanoparticle mediated siRNA delivery.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.Layer-by-Layer Assemblies for Cancer Treatment and Diagnosis
P2860
Q26776095-2B19A3F7-00B9-4E61-A1C0-D4BDBE9AEE63Q26866172-171EC8C4-FA39-4225-AAA1-594E803D4F79Q26866566-9FDF94E5-2CC4-45DE-A1A8-E4F95BCCD5DAQ28257050-8E8BA142-4CC2-427A-B8A3-7DE3FCD86150Q28834339-0AD95CA0-91A5-4E30-A8AF-8DCA6D84D32EQ30362001-E3C18819-296A-439A-9631-972F8218B411Q30749087-11AB2F7A-24E7-4546-96CC-0D531076EA58Q30757601-7121FB05-67BE-4BDB-BC50-08BD2FA18052Q33594253-3C4C7FC4-FEB1-4832-BBBF-1D5073762E26Q33611947-1579C9BE-A288-4658-BEB4-25D938063A52Q33635355-AF2E88ED-26C9-4E46-9B9D-715E3CE821D0Q33766568-78B4EEFE-DE4C-42F3-B3B5-A7AE9A5F75A9Q33926857-023B7441-B2EE-48C3-9688-D2AA01A7B98FQ34002480-B20E4435-5178-4665-9596-F8C37887400DQ34062299-66FC3517-FA8A-4D3C-AD23-C43DEE875C90Q34104372-E0A6F04C-1752-41CF-A190-0AAFF65D38CCQ34135640-90EDBC1F-1B50-423C-BDEA-C2B12E44A2F9Q34419904-446137AE-0D4E-4600-AC0C-CA56A32CEEFCQ34579964-C5981696-4363-46C8-A9A2-61CC2EA86DE7Q34723882-B28DF724-7199-4592-A689-7E8960641B2AQ34986234-B2C62185-1139-43C3-87C5-D9F748CB69E6Q35192978-038BDF66-3631-4E48-9804-DFE7F9719B60Q35965771-C93CE800-7824-4F98-9FEC-92BF7155A8E1Q36137279-1C249F04-1DAC-48A7-AC25-1A8B3A856E20Q36219160-3308E6E1-A594-41E8-94AB-F21D64DCA592Q36307555-BF359CCC-064D-42FF-9BB4-29B1F13D3F65Q36352658-9F411369-DD24-45A5-97EF-E3DAA095DFEEQ36354955-D03102F7-6ED7-40C8-821E-6A03DB198380Q36372319-69B3D450-F97D-4F2F-BCBA-2DACF357DC94Q36622859-0E46ECAD-E949-4424-A0F6-FF8424BE69E1Q36784555-9D8D2BCF-1352-45C2-B483-9A4245EE2180Q36807989-35D0C169-0510-42DE-B69B-2C0C28AA0770Q37404658-939A7D9C-7B72-46F0-827A-8A6C11560179Q37469872-DBC8D4F6-9F3E-4555-9E3D-4123D3FE43D2Q37573748-C91BABFB-F575-45E0-8FE2-410871CC619EQ38172476-B7C58C6B-D97A-4CAC-84E9-DEBD9D7BFD0BQ38212473-89F787C8-4386-4479-B0E7-45A1C14D0721Q38324456-95E3AEEA-CDBD-4C1D-B152-0614CEC8902CQ38555082-A152E4F0-BE1B-4B79-8D29-7EB7E02C685BQ38590390-2E15A00A-E849-45C0-ADA5-CA4513BD1E4C
P2860
Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Layer-by-layer nanoparticles f ...... gative breast cancer treatment
@en
Layer-by-layer nanoparticles f ...... ative breast cancer treatment.
@nl
type
label
Layer-by-layer nanoparticles f ...... gative breast cancer treatment
@en
Layer-by-layer nanoparticles f ...... ative breast cancer treatment.
@nl
prefLabel
Layer-by-layer nanoparticles f ...... gative breast cancer treatment
@en
Layer-by-layer nanoparticles f ...... ative breast cancer treatment.
@nl
P2093
P2860
P356
P1433
P1476
Layer-by-layer nanoparticles f ...... gative breast cancer treatment
@en
P2093
Elana Ben-Akiva
Erik C Dreaden
Kevin E Shopsowitz
Stephen W Morton
Zhou J Deng
P2860
P304
P356
10.1021/NN4047925
P407
P577
2013-10-21T00:00:00Z